Acuitas Therapeutics Co-Authoring a Study That Shows Early Promise for an mRNA Vaccine Targeting All Known Flu Strains
VANCOUVER, BC — A new study co-authored by scientists from the University of Pennsylvania and Vancouver-based biotechnology firm Acuitas Therapeutics shows early promise for an mRNA vaccine targeting all known… Read More




